logo
Inox India share price rises 3% on securing multiple orders worth ₹373 cr

Inox India share price rises 3% on securing multiple orders worth ₹373 cr

Inox India share price: Cryogenic technology solution provider Inox India share price rose as much as 3.15 per cent to hit an intraday high of ₹1,219.95 per share on Tuesday, June 17, 2025.
At 12:10 PM, Inox India share price was trading 0.62 per cent higher at ₹1,189.90 per share. In comparison, BSE Sensex was trading 0.28 per cent lower at 81,567.80 levels.
Why did Inox India share price rise in trade today?
Inox India share price gained after the company announced that it has secured multiple orders worth ₹373 crore so far in the current financial year, spanning all key business segments—Industrial Gas, Cryo-scientific Solutions, LNG, and Beverage Kegs.
The order breakdown includes ₹151 crore in Cryo-scientific Solutions, ₹141 crore in Industrial Gas, and ₹71 crore in the LNG segment.
'These orders reflect continued trust from global and domestic customers in INOX India's advanced cryogenic systems and capabilities,' Inox India said.
The company has bagged a 'Major' contract from ITER for repairs to the Cryostat Thermal Shield. It has also received several 'Large' and 'Minor' orders for LNG storage tanks, industrial gas storage tanks, transport tanks, dispensers, and disposable cylinders.
Additionally, Inox India secured a 'Minor' order from a German customer for the supply of
beverage kegs.
The order classification by value includes minor (₹10–30 crore), large (₹30–60 crore), significant (₹60–100 crore), major (₹100–150 crore), and mega (above ₹150 crore).
'These orders reinforce our position as a trusted global partner for critical cryogenic solutions. Besides our growing presence across segments and markets, we are equally excited about the growing applications and use-cases for cryogenic solutions, especially in the clean energy space. The positive impact created by our solutions, inspires us to raise the bar of cryogenic excellence. We remain committed to delivering high-quality and innovative cryogenic equipment to customers worldwide,' said Deepak Acharya, chief executive officer, Inox India.
About Inox India
Inox India is a global leader in the manufacturing of cryogenic storage, regasification, and distribution systems for LNG, industrial gases, liquid hydrogen, and cryo-scientific applications.
With a strong presence across India, Brazil, and Europe, the company serves a vast customer base in over 100 countries. Its robust network of after-sales support associates spans 25 countries, ensuring reliable service and support worldwide.
It also plays a pivotal role in advancing India's transition to LNG for industrial and automotive use. The company is recognised for its expertise in design engineering, manufacturing, and delivery of turnkey cryogenic packaged systems.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

'Instead of supporting Israel's just war...': Netanyahu says German arms export halt 'rewarding Hamas'
'Instead of supporting Israel's just war...': Netanyahu says German arms export halt 'rewarding Hamas'

First Post

time6 hours ago

  • First Post

'Instead of supporting Israel's just war...': Netanyahu says German arms export halt 'rewarding Hamas'

Israel's Prime Minister Benjamin Netanyahu on Friday slammed Germany's decision to suspend arms exports to Israel over the ongoing Gaza conflict, saying the move would only strengthen Hamas read more Israel's Prime Minister Benjamin Netanyahu on Friday slammed Germany's decision to suspend arms exports to Israel over the ongoing Gaza conflict, saying the move would only strengthen Hamas. 'Instead of supporting Israel's just war against Hamas, which carried out the most horrific attack against the Jewish people since the Holocaust, Germany is rewarding Hamas terrorism by embargoing arms to Israel,' AFP quoted Netanyahu's office as saying in a statement. The prime minister also conveyed his 'disappointment' directly to German Chancellor Friedrich Merz during a phone call, the statement added. STORY CONTINUES BELOW THIS AD Germany on Friday announced that it will suspend exports of weapons that could be used in the Gaza Strip, marking the first time since reunification that Berlin has publicly acknowledged curbing military support to its close ally Israel. The shift, announced by Chancellor Friedrich Merz, comes amid growing public pressure and demands from his junior coalition partner over the worsening humanitarian crisis in Gaza, where Israel has sharply restricted access to food, water, and other essentials. In a statement, Merz reiterated Germany's support for Israel's right to target Hamas and secure the release of hostages but warned that Israel's expanded military plans 'make it increasingly difficult to see how these goals can be achieved.' Germany is Israel's second-largest arms supplier after the United States and has historically backed the country as part of its post-Holocaust policy of 'Staatsraison' — a state commitment to Israel's security. However, a June opinion poll showed shifting public sentiment, with 73% of Germans supporting tighter controls on arms exports, and nearly a third backing a complete ban. With inputs from agencies

GSK set to get $500 million from settlement of mRNA lawsuit
GSK set to get $500 million from settlement of mRNA lawsuit

Economic Times

time6 hours ago

  • Economic Times

GSK set to get $500 million from settlement of mRNA lawsuit

Live Events (You can now subscribe to our (You can now subscribe to our Economic Times WhatsApp channel CureVac NV has settled a long-running patent dispute over mRNA vaccines with Pfizer and BioNTech SE in the US, which will see CureVac's former collaborator GSK receive as much as $500 million and 1% of royalties from future vaccine settlement comes as BioNTech looks to close the purchase of its former rival CureVac for about $1.25 billion. GSK will receive $370 million upfront, with another $130 million on the closing of the the wake of the race to develop Covid-19 vaccines, drugmakers launched multiple lawsuits against one another over alleged patent infringement. The litigation has spanned across Europe and the US, pitting rival vaccine manufacturers against one another in the worked with CureVac to develop Covid-19 vaccines but they failed, losing out to quicker, nimbler rivals. Last year, the two companies restructured their collaboration, with GSK paying CureVac up to $1.4 billion for the full rights to mRNA flu and Covid-19 vaccines it was developing with the German will also receive 1% on royalties of future Pfizer-BioNTech sales of flu, Covid-19 and related combination mRNA vaccines in the US. Once BioNTech completes the purchase of CureVac, GSK will also receive 1% of royalties from future sales outside the the settlement ends CureVac's litigation with Pfizer and BioNTech, it doesn't mean the same for GSK. The British drugmaker said it will continue its litigation against BioNTech and Pfizer for what it alleges is infringement of its patents.

Bayern Munich Shifts Away From 'Visit Rwanda' Sponsorship After Criticism
Bayern Munich Shifts Away From 'Visit Rwanda' Sponsorship After Criticism

NDTV

time8 hours ago

  • NDTV

Bayern Munich Shifts Away From 'Visit Rwanda' Sponsorship After Criticism

Bayern Munich signaled Friday it will cut down on 'Visit Rwanda' branding as it moves 'away from a commercial sponsorship' with the African nation facing a backlash over alleged support for rebels in neighboring Congo. Bayern dismissed allegations of 'sportswashing' when it signed a five-year Rwanda deal in 2023. It included advertisements in the stadium and what Bayern called events 'to promote tourism and investment opportunities in Rwanda.' At the time, it replaced a controversial sponsorship deal with Qatar. Rwanda has similar sponsorships with European soccer giants like Paris Saint-Germain, Arsenal and Atletico Madrid. Some Bayern fans displayed a large banner at a game in February protesting the deal, amid accusations from the United Nations that Rwanda has backed rebels in neighboring Congo. Now the German soccer champion says it's reached a new deal with Rwanda which turns the existing sponsorship deal into a three-year agreement focusing on developing young soccer players at a Bayern-affiliated academy in the country. 'In constructive talks about our future direction, we agreed that a very special part of our relationship with (the Rwanda Development Board) was the developmental nature of our work in Kigali through the FC Bayern Academy,' Bayern chief executive Jan-Christian Dreesen said in a statement. "We are therefore transforming our commercial partnership into a talent programme and expanding the FC Bayern Academy in (Rwanda's capital) Kigali together with the RDB as both a football and social initiative. This remains perfectly aligned to our strategic objective of developing playing talent in Africa.' Bayern didn't specify how soon it would drop 'Visit Rwanda' branding as part of the move, which is described as a transition. As of Friday afternoon local time, the branding was still displayed under a section of the Bayern website listing club sponsors and partners. The RDB's chief executive, Jean-Guy Afrika, was quoted by Bayern as saying the changes to the partnership aimed to 'accelerate sports development,' adding: "This continued partnership with FC Bayern helps ensure that talent development remains anchored in our broader vision to position Rwanda as a global hub for tourism, investment, and high-performance sport.' Rwanda's presence in European soccer has grown steadily since 2018, when it first partnered with Arsenal to put 'Visit Rwanda' branding on the London club's shirt sleeves. An agreement with PSG was signed in 2019 and renewed in April this year. It covers branding in the stadium and included shirt-sleeve sponsorship at the Club World Cup. A three-year deal to sponsor Atletico was agreed in April including branding on training and warm-up shirts. Rwanda is accused of supporting the M23 rebel group, the most potent of more than 100 armed groups vying for dominance in mineral-rich eastern Congo just across the border with Rwanda. Rwanda also has been accused of exploiting eastern Congo's minerals, used in smartphones, advanced fighter jets and much more. However, Rwandan authorities allege some of those who participated in the 1994 Rwandan genocide fled into Congo and are either working with or are being protected by the Congolese army. They have denied involvement in Congo's minerals sector and said any security action taken is to protect its territory.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store